20 research outputs found
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8(+) and CD4(+) T-cell responses with multiple specificities including a novel DR7-restricted epitope.
Long synthetic peptides and CpG-containing oligodeoxynucleotides are promising components for cancer vaccines. In this phase I trial, 19 patients received a mean of 8 (range 1-12) monthly vaccines s.c. composed of the long synthetic NY-ESO-179-108 peptide and CpG-B (PF-3512676), emulsified in Montanide ISA-51. In 18/18 evaluable patients, vaccination induced antigen-specific CD8(+) and CD4(+) T-cell and antibody responses, starting early after initiation of immunotherapy and lasting at least one year. The T-cells responded antigen-specifically, with strong secretion of IFNγ and TNFα, irrespective of patients' HLAs. The most immunogenic regions of the vaccine peptide were NY-ESO-189-102 for CD8(+) and NY-ESO-183-99 for CD4(+) T-cells. We discovered a novel and highly immunogenic epitope (HLA-DR7/NY-ESO-187-99); 7/7 HLA-DR7(+) patients generated strong CD4(+) T-cell responses, as detected directly ex vivo with fluorescent multimers. Thus, vaccination with the long synthetic NY-ESO-179-108 peptide combined with the strong immune adjuvant CpG-B induced integrated, robust and functional CD8(+) and CD4(+) T-cell responses in melanoma patients, supporting the further development of this immunotherapeutic approach
Acetylcholine Receptor-specific CD4+ T Cells in Myasthenia Gravis Patients Have Individual, but Restricted TCR Vbeta Usagea
CD4+ Epitope Spreading and Differential T Cell Recognition of Muscle Acetylcholine Receptor Subunits in Myasthenia Gravisa
Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes.
Human Melanoma Cells Transfected with the B7-2 Co-Stimulatory Molecule Induce Tumor-Specific CD8 +
High-throughput Screening of Human Tumor Antigen-specific CD4 T Cells, Including Neoantigen-reactive T Cells.
Characterization of tumor antigen-specific CD4 T-cell responses in healthy donors and malignant melanoma patients using an in vitro amplified T-cell library screening procedure.
A high-throughput, human leukocyte antigen (HLA)-independent approach was used to estimate at unprecedented high sensitivity level precursor frequencies of tumor antigen- and neoantigen-specific CD4 T cells in healthy donors and patients with cancer. Frequency estimation was combined with isolation and functional characterization of identified tumor-reactive CD4 T-cell clones.
In healthy donors, we report frequencies of naïve tumor-associated antigen (TAA)-specific CD4 T cells comparable with those of CD4 T cells specific for infectious agents (Tetanus toxoid). Interestingly, we also identified low, but consistent numbers of memory CD4 T cells specific for several TAAs. In patients with melanoma, low frequencies of circulating TAA-specific CD4 T cells were detected that increased after peptide-based immunotherapy. Such antitumor TAA-specific CD4 T-cell responses were also detectable within the tumor-infiltrated tissues. TAA-specific CD4 T cells in patients displayed a highly polyfunctional state, with partial skewing to Type-2 polarization. Finally, we report the applicability of this approach to the detection and amplification of neoantigen-specific CD4 T cells.
This simple, noninvasive, high-throughput screening of tumor- and neoantigen-specific CD4 T cells requires little biologic material, is HLA class II independent and allows the concomitant screening for a large number of tumor antigens of interest, including neoantigens. This approach will facilitate the immunomonitoring of preexisting and therapy-induced CD4 T-cell responses, and accelerate the development of CD4 T-cell-based therapies
Comparative study of the radiobiological effects induced on adherent vs suspended cells by BNCT, neutrons and gamma rays treatments
The present work is part of a preclinical in vitro study to assess the efficacy of BNCT applied to liver or lung coloncarcinoma metastases and to limb osteosarcoma. Adherent growing cell lines can be irradiated as adherent to the culture flasks or as cell suspensions, differences in radio-sensitivity of the two modalities of radiation exposure have been investigated. Dose related cell survival and cell cycle perturbation results evidenced that the radiosensitivity of adherent cells is higher than that of the suspended ones.Fil: Cansolino, L.. University of Pavia; Italia. Matteo Hospital; ItaliaFil: Clerici, A.M.. University of Pavia; ItaliaFil: Zonta, C.. University of Pavia; ItaliaFil: Dionigi, P.. University of Pavia; Italia. Matteo Hospital; ItaliaFil: Mazzini, G.. University of Pavia; ItaliaFil: Di Liberto, R.. Matteo Hospital; ItaliaFil: Altieri, S.. Istituto Nazionale Di Fisica Nucleare, Sezione Di Pavia; . Università Degli Studi Di Pavia;Fil: Ballarini, F.. University of Pavia; Italia. Istituto Nazionale Di Fisica Nucleare; ItaliaFil: Bortolussi, S.. Istituto Nazionale Di Fisica Nucleare; ItaliaFil: Carante, M.P.. Istituto Nazionale Di Fisica Nucleare; Italia. University of Pavia; ItaliaFil: Ferrari, M.. Istituto Nazionale Di Fisica Nucleare; Italia. University of Pavia; ItaliaFil: González, Sara Josefina. Comisión Nacional de Energía Atómica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Postuma, I.. Istituto Nazionale Di Fisica Nucleare; Italia. University of Pavia; ItaliaFil: Protti, N.. Istituto Nazionale Di Fisica Nucleare; Italia. University of Pavia; ItaliaFil: Santa Cruz, G.A.. Comisión Nacional de Energía Atómica; ArgentinaFil: Ferrari, C.. University of Pavia; Itali
T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors
Donor-derived allogeneic T cells evoke potent graft versus tumor (GVT) effects likely due to the simultaneous recognition of tumor-specific and host-restricted minor histocompatibility (H) antigens. Here we investigated whether such effects could be reproduced in autologous settings by TCR gene–engineered lymphocytes. We report that T cells redirected either to a broadly expressed Y-encoded minor H antigen or to a tumor-associated antigen, although poorly effective if individually transferred, when simultaneously administered enabled acute autochthonous tumor debulking and resulted in durable clinical remission. Y-redirected T cells proved hyporesponsive in peripheral lymphoid organs, whereas they retained effector function at the tumor site, where in synergy with tumor-redirected lymphocytes, they instructed TNFα expression, endothelial cell activation, and intratumoral T-cell infiltration. While neutralizing TNFα hindered GVT effects by the combined T-cell infusion, a single injection of picogram amounts of NGR-TNF, a tumor vessel–targeted TNFα derivative currently in phase III clinical trials, substituted for Y-redirected cells and enabled tumor debulking by tumor-redirected lymphocytes. Together, our results provide new mechanistic insights into allogeneic GVT, validate the importance of targeting the tumor and its associated stroma, and prove the potency of a novel combined approach suitable for immediate clinical implementation
Pilot studies to evaluate the effectiveness of high LET particle irradiation in damaging neurotoxic protein aggregates
A growing number of diseases, namely amyloidosis, are associated to an abnormal production
or reduced clearance of proteins assuming insoluble aggregated structures which deposit in the
intra- and extracellular brain compartments. Alzheimer’s disease (AD) is one of the most
frequent amyloidosis where Aβ aggregates deposited in the brain as senile plaques. The Aβ
peptide results as the culprit of the neuropathological process. The aging of the world population
foreseen for the next decades is expected to increase AD and other dementia incidence, implying
both a higher number of patients in need of caregiver's assistance and huge socio-economical
costs. These prospects heighten the concern about the lack of therapeutic tools able to
significantly slow down the disease progression